Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002364097 | SCV002625851 | uncertain significance | Cardiovascular phenotype | 2021-12-24 | criteria provided, single submitter | clinical testing | The p.V1283L variant (also known as c.3847G>C), located in coding exon 9 of the TNXB gene, results from a G to C substitution at nucleotide position 3847. The valine at codon 1283 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |